Forward viewing catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS)
前视导管微泡增强超声溶栓 (FV-CAMUS)
基本信息
- 批准号:9982126
- 负责人:
- 金额:$ 51.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcousticsAcuteAffectAlteplaseAmericanAnimalsBasic ScienceBlood coagulationCaliberCathetersCessation of lifeClinicalCoagulation ProcessContrast MediaCytolysisDeep Vein ThrombosisDevelopmentDevicesDiseaseDistalDrug Delivery SystemsEmbolismEndotheliumFailureFamily suidaeFemoral veinFibrinolysisFibrinolytic AgentsFocused UltrasoundFrequenciesFunctional disorderGoalsHeatingHemorrhageHourIn VitroInjectionsInjuryIntravenousLegLettersLungLyticMalignant NeoplasmsMeasuresMechanicsMediatingMicrobubblesModelingMonitorMorbidity - disease rateOutputPainParticle SizePathologicPatientsPenetrationPerformancePeripheralPharmaceutical PreparationsPharmacologyPostphlebitic SyndromeProceduresPulmonary EmbolismQuality of lifeRecurrenceResearchResidual stateRiskSafetySideSourceSurvivorsSystemTechniquesTechnologyTestingThrombectomyThrombosisThrombusTimeTissuesTransducersTranslation ProcessTubeUlcerUltrasonic TransducerUltrasonographyValidationVascular DiseasesVeinsVenousWorkbaseboneclinical translationclinically significantcontrast enhanceddeep veindesigneffective therapyimprovedin vivoin vivo evaluationinnovationinnovative technologiesinterestmortalitynanoDropletnew technologynovelnovel strategiesoutcome forecastpatient populationphase changeprototypethrombolysistool
项目摘要
Forward viewing catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS)
Deep vein thrombosis (DVT) induced pulmonary embolism (PE) causes more than 0.1 million deaths annually
in the US alone. Recent innovative treatment techniques for thrombolysis, such as pharmacological dissolution
or fibrinolysis and mechanical fragmentation, have showed progressive results, yet still suffer from severe
limitations such as low thrombolysis efficiency and long treatment times, frequent bleeding complications, high
failure rate, vein injury associated with severe regional dysfunction, recurrence, and the relatively large particle
size of residual clot debris which can result in distal embolism. This has led to great interest in sonothrombolysis,
the use of focused ultrasound to disrupt clots, yet current commercial sonothrombolysis systems (e.g. EKOS)
are still limited by long treatment times and peripheral tissue damage due to heating and excessive acoustic
exposure. More recently, our group and others have demonstrated several advances which promise to improve
the performance (significantly reduced treatment time) and safety of thrombolysis using a microbubble-mediated
forward-looking dual frequency catheter based technology. We hypothesize that the development of a new
approach for catheter sonothrombolysis combining multi-frequency tools as well as cavitation-enhancing agents
can substantially improve the efficacy, safety, and impact of this approach. In this project, we develop innovative
technologies from our collaborative group, each of which has shown notable advantages over current
technology, and we hypothesize that together they can overcome existing challenges in the aforementioned
acute embolism treatments. Specifically, a 4-French catheter will be integrated with dual acoustic sources - a
small aperture dual frequency forward-looking ultrasound transducer, combined with a micro-tube for delivery of
microbubbles and lytic agent (tissue-type plasminogen activator or t-PA), to achieve Forward Viewing CAtheter-
delivered MicrobUbble enhanced Sonothrombolysis (FV-CAMUS). The FV-CAMUS catheter will be designed,
prototyped and characterized, followed by in-vitro, ex-vivo and in-vivo thrombolysis tests in large animals. The
proposed FV-CAMUS technology will provide a new tool enabling accurate, fast, and safe thrombus treatment.
前视导管微泡增强超声溶栓(FV-CAMUS)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaoning Jiang其他文献
Xiaoning Jiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaoning Jiang', 18)}}的其他基金
Forward viewing catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS)
前视导管微泡增强超声溶栓 (FV-CAMUS)
- 批准号:
9755499 - 财政年份:2018
- 资助金额:
$ 51.63万 - 项目类别:
Forward viewing catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS)
前视导管微泡增强超声溶栓 (FV-CAMUS)
- 批准号:
10219344 - 财政年份:2018
- 资助金额:
$ 51.63万 - 项目类别:
Dual-frequency intravascular arrays for functional imaging of atherosclerosis
用于动脉粥样硬化功能成像的双频血管内阵列
- 批准号:
8849910 - 财政年份:2012
- 资助金额:
$ 51.63万 - 项目类别:
Dual-frequency intravascular arrays for functional imaging of atherosclerosis
用于动脉粥样硬化功能成像的双频血管内阵列
- 批准号:
8668055 - 财政年份:2012
- 资助金额:
$ 51.63万 - 项目类别:
Dual-frequency intravascular arrays for functional imaging of atherosclerosis
用于动脉粥样硬化功能成像的双频血管内阵列
- 批准号:
8516039 - 财政年份:2012
- 资助金额:
$ 51.63万 - 项目类别:
Dual-frequency intravascular arrays for functional imaging of atherosclerosis
用于动脉粥样硬化功能成像的双频血管内阵列
- 批准号:
8346523 - 财政年份:2012
- 资助金额:
$ 51.63万 - 项目类别:
Micromachined Piezoelectric 2-D Arrays for 3-D Medical Imaging
用于 3D 医学成像的微机械压电 2D 阵列
- 批准号:
7326526 - 财政年份:2007
- 资助金额:
$ 51.63万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 51.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 51.63万 - 项目类别:
Standard Grant














{{item.name}}会员




